WWW.PHARMAORG.COM WWW.PHARMAORG.COM: Any drug you wish to know about


SKELAXIN       

      Skelaxin is a muscle relaxant. Skelaxin is used to treat the pain and stiffness of muscle injuries, including strains, sprains and muscle spasms.

How Taken
Skelaxin comes as a tablet to take by mouth. The recommended dose for adults and children over 12 years of age is two tablets (800 mg) three to four times a day. Skelaxin may be taken with food or immediately after meals to prevent stomach upset. Do not increase your dose, take it more frequently or take it for a longer period of time than prescribed by your doctor.

Warnings/Precautions
Do not take Skelaxin if you have acute intermittent porphyria. Before taking Skelaxin, tell your doctor if you have liver disease. You may need a lower dose or special monitoring during your therapy. It is not known whether Skelaxin will harm an unborn baby. Do not take Skelaxin without first talking to your doctor if you are pregnant. It is also not known whether Skelaxin passes into breast milk. Do not take Skelaxin without first talking to your doctor if you are breast-feeding a baby. Skelaxin is not approved for use in children younger than 12 years of age.

Missed Dose
If you miss a dose of Skelaxin, take as soon as remembered within 1 hour. Otherwise skip that dose and resume usual dosing schedule. Do not "double-up" the dose to catch up.

Possible Side Effects
The most frequent reactions to Skelaxin include nausea, vomiting, gastrointestinal upset, drowsiness, dizziness, headache, and nervousness or "irritability." Other adverse reactions are: hypersensitivity reactions, characterized by a light rash with or without pruritus; leukopenia; hemolytic anemia; jaundice.

Searching for something else? No problem!

Search for anything:

Sleep Apnea May Herald Early Heart Disease.
         The snoring and constant awakenings of severe sleep apnea could provide an early indication of heart disease, researchers report. Brazilian researchers detected early hardening of the arteries in 42- to 44-year-old patients with severe obstructive sleep apnea, despite the absence of overt signs of cardiovascular disease. People with obstructive sleep apnea repeatedly stop breathing in their sleep as a result of partial or complete blockage of the upper airway. The vascular abnormalities detected by researchers correlated significantly with the severity of the patient's sleep apnea, noted lead researcher Dr. Luciano F. Drager of the Heart Institute at the University of Sao Paulo Medical School.
Main Page   Site Map